Inventor · disambiguated record
Tao Sai
Also filed as: SAI TAO
15 granted patents·6 pending applications·45 citations·filing 2008–2024
91Inventor score
Top patents by PatentIndex Score
21 records- 0192US11377500B2Antibodies specific for CD70 and their usesPFIZER·Filed 2019·Granted Jul 5, 2022·8 cites·36 claims
- 0291US10421822B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 24, 2019·4 cites·52 claims
- 0387US8236932B2High affinity antibodies that neutralize Staphylococcus enterotoxin BSASS PHILIP M·Filed 2008·Granted Aug 7, 2012·8 cites·24 claims
- 0486US8895704B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2013·Granted Nov 25, 2014·6 cites·6 claims
- 0586US8889846B2High affinity antibodies that neutralize Staphylococcus enterotoxin BSASS PHILIP M·Filed 2012·Granted Nov 18, 2014·6 cites·17 claims
- 0686US2024067752A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2023·Application pending·0 cites
- 0785US11396551B2Chimeric antigen receptors targeting CD70PFIZER·Filed 2019·Granted Jul 26, 2022·2 cites·47 claims
- 0885US10421821B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 24, 2019·2 cites·44 claims
- 0984US9359428B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2014·Granted Jun 7, 2016·4 cites·4 claims
- 1083US11512143B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2019·Granted Nov 29, 2022·1 cites·21 claims
- 1182US9868780B2High affinity antibodies that neutralize Staphylococcus enterotoxin BMORPHOTEK INC·Filed 2016·Granted Jan 16, 2018·2 cites·4 claims
- 1282US2023383008A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2022·Application pending·0 cites
- 1378US2025145725A1Chimeric antigen receptors targeting cd70PFIZER·Filed 2024·Application pending·0 cites
- 1478US2025011446A1Antibodies specific for cd70 and their usesPFIZER·Filed 2024·Application pending·0 cites
- 1575US12152081B2Chimeric antigen receptors targeting CD70PFIZER·Filed 2022·Granted Nov 26, 2024·0 cites·42 claims
- 1675US11987634B2Antibodies specific for CD70 and their usesPFIZER·Filed 2022·Granted May 21, 2024·0 cites·33 claims
- 1766US10364284B2High affinity antibodies that neutralize Staphylococcus enterotoxin BEISAI INC·Filed 2017·Granted Jul 30, 2019·0 cites·4 claims
- 1866US2024101710A1B-cell maturation antigen (bcma) anti-idiotypic antibodiesALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1963US9562097B2Use of anti-CD83 agonist antibodies for treating autoimmune diseasesDIEHL LAURI·Filed 2012·Granted Feb 7, 2017·2 cites·21 claims
- 2062US2024216430A1Claudin 18.2 targeting chimeric antigen receptors and binding agents and uses thereofALLOGENE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2151US11732041B2Antibodies against 4G7-derived chimeric antigen receptorsALLOGENE THERAPEUTICS INC·Filed 2020·Granted Aug 22, 2023·0 cites·29 claims
Join the waitlist — get patent alerts
Get an alert when Tao Sai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →